Designing Longevity
Skip to main content

Plecanatide (Trulance)

Plecanatide, sold as Trulance in the U.S., is a prescription peptide that increases intestinal fluid secretion. It is FDA-approved for adults with chronic idiopathic constipation or IBS with constipation.

Sources reviewed November 13, 2026 · How we work

How plecanatide works

Plecanatide acts on guanylate cyclase-C in the intestinal lining, increasing fluid secretion and helping stool move through the intestine. Trulance is supplied as a 3 mg tablet. The same tablet has evidence from separate trials for the two labeled uses.

Sources for this section

What each set of trials measured

The adult IBS-C trials required improvement in both abdominal pain and complete spontaneous bowel movements to count someone as a responder. The chronic idiopathic constipation trials looked for sustained improvement in complete bowel movements. The comparisons below show the result against placebo for each condition.

Sources for this section

Safety and labeled eligibility

Diarrhea is the most common adverse reaction and can be severe. The label has a boxed warning about serious dehydration in children younger than 6, for whom the medicine is contraindicated. It also advises avoiding use from ages 6 through 17. Known or suspected mechanical bowel obstruction is a contraindication.

Sources for this section
Explore Gut Health & Digestion